IPTACOPAN ASH UPDATE

Two positive Ph3 studies in PNH are the first pivotal readouts for iptacopan Study APPLY-PNH Patient type PNH patients with residual anemia despite anti-C5 APPOINT-PNH PNH patients naive to complement inhibitor therapy Intervention Iptacopan vs. anti-C5 antibody Iptacopan, single-arm study SOCIETY AMERICAN OF 6 IPTACOPAN ASH UPDATE | DECEMBER 13, 2022 HEMATOLOG NOVARTIS | Reimagining Medicine

View entire presentation